EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Moderate-Intensity Rosuvastatin Plus Ezetimibe Versus High-Intensity Rosuvastatin for Target Low-Density Lipoprotein Cholesterol Goal Achievement in Patients With Recent Ischemic Stroke: A Randomized Controlled Trial

Keun-Sik Hong, Oh Young Bang, Jong-Ho Park, Jin-Man Jung, Sang-Hun Lee, Tae-Jin Song, Hyo Suk Nam, Hee-Kwon Park, Keun-Hwa Jung, Sung Hyuk Heo, Jaseong Koo, Kyung-Ho Yu und 6 weitere

Journal of Stroke · 31.05.2023 · 25 (2) · 242-250

DOI: 10.5853/jos.2022.02957 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Stroke, erschienen am 31.05.2023. Verfasst von Keun-Sik Hong und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Ilsan Paik Hospital, Inje University, Goyang, Korea. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Hanmi Pharm. Co., Ltd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Moderate-intensity statin plus ezetimibe versus high-intensity statin alone may provide a greater low-density lipoprotein cholesterol (LDL-C) reduction in patients with recent ischemic stroke.Methods This randomized, open-label, controlled trial assigned patients with recent ischemic stroke

Schlagwörter

Stichwörter der Autor:innen

EzetimibeLDL cholesterolRosuvastatinStrokeTarget goal

Autor:innen und Institutionen

  • Department of Neurology, Ilsan Paik Hospital, Inje University, Goyang, Korea.
  • Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Department of Neurology, Myongji Hospital, Hanyang University College of Medicine, Goyang, Korea.
  • Department of Neurology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.
  • Department of Neurology, Seoul Hospital, Ewha Women's University College of Medicine, Seoul, Korea.
  • Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.

Förderung

  • Hanmi Pharm. Co., Ltd

Zitieren

APA

Hong, K. S., Bang, O. Y., Park, J. H., Jung, J. M., Lee, S. H., Song, T. J., Nam, H. S., Park, H. K., Jung, K. H., Heo, S. H., Koo, J., Yu, K. H., Park, K. Y., Kim, C. K., Park, H. K., Lee, J., Lee, J., & Seo, W. K. (2023). Moderate-Intensity Rosuvastatin Plus Ezetimibe Versus High-Intensity Rosuvastatin for Target Low-Density Lipoprotein Cholesterol Goal Achievement in Patients With Recent Ischemic Stroke: A Randomized Controlled Trial. Journal of Stroke, 25(2), 242-250. https://doi.org/10.5853/jos.2022.02957

Vancouver

Hong KS, Bang OY, Park JH, Jung JM, Lee SH, Song TJ, et al. Moderate-Intensity Rosuvastatin Plus Ezetimibe Versus High-Intensity Rosuvastatin for Target Low-Density Lipoprotein Cholesterol Goal Achievement in Patients With Recent Ischemic Stroke: A Randomized Controlled Trial. Journal of Stroke. 2023;25(2):242-250. doi:10.5853/jos.2022.02957

BibTeX
@article{Hong2023,
  author = {Hong, Keun-Sik and Bang, Oh Young and Park, Jong-Ho and Jung, Jin-Man and Lee, Sang-Hun and Song, Tae-Jin and Nam, Hyo Suk and Park, Hee-Kwon and Jung, Keun-Hwa and Heo, Sung Hyuk and Koo, Jaseong and Yu, Kyung-Ho and Park, Kwang-Yeol and Kim, Chi Kyung and Park, Hong-Kyun and Lee, Jiyoon and Lee, Juneyoung and Seo, Woo-Keun},
  title = {Moderate-Intensity Rosuvastatin Plus Ezetimibe Versus High-Intensity Rosuvastatin for Target Low-Density Lipoprotein Cholesterol Goal Achievement in Patients With Recent Ischemic Stroke: A Randomized Controlled Trial},
  journal = {Journal of Stroke},
  year = {2023},
  volume = {25},
  number = {2},
  pages = {242--250},
  doi = {10.5853/jos.2022.02957}
}
Kostenlos starten →